Literature DB >> 31124171

Breast Cancer Brain Metastasis Response to Radiation After Microbubble Oxygen Delivery in a Murine Model.

Lauren J Delaney1, Lorela Ciraku2, Brian E Oeffinger3, Corinne E Wessner1, Ji-Bin Liu1, Jingzhi Li1,4, Kibo Nam1, Flemming Forsberg1, Dennis B Leeper5, Patrick O'Kane1, Margaret A Wheatley3, Mauricio J Reginato2, John R Eisenbrey1.   

Abstract

OBJECTIVES: Hypoxic cancer cells have been shown to be more resistant to radiation therapy than normoxic cells. Hence, this study investigated whether ultrasound (US)-induced rupture of oxygen-carrying microbubbles (MBs) would enhance the response of breast cancer metastases to radiation.
METHODS: Nude mice (n = 15) received stereotactic injections of brain-seeking MDA-MB-231 breast cancer cells into the right hemisphere. Animals were randomly assigned into 1 of 5 treatment groups: no intervention, 10 Gy radiation using a small-animal radiation research platform, nitrogen-carrying MBs combined with US-mediated MB rupture immediately before 10 Gy radiation, oxygen-carrying MBs immediately before 10 Gy radiation, and oxygen-carrying MBs with US-mediated MB rupture immediately before 10 Gy radiation. Tumor progression was monitored with 3-dimensional US, and overall survival was noted.
RESULTS: All groups except those treated with oxygen-carrying MB rupture and radiation had continued rapid tumor growth after treatment. Tumors treated with radiation alone showed a mean increase in volume ± SD of 337% ± 214% during the week after treatment. Tumors treated with oxygen-carrying MBs and radiation without MB rupture showed an increase in volume of 383% ± 226%. Tumors treated with radiation immediately after rupture of oxygen-carrying MBs showed an increase in volume of only 41% ± 1% (P = 0.045), and this group also showed a 1 week increase in survival time.
CONCLUSIONS: Adding US-ruptured oxygen-carrying MBs to radiation therapy appears to delay tumor progression and improve survival in a murine model of metastatic breast cancer.
© 2019 by the American Institute of Ultrasound in Medicine.

Entities:  

Keywords:  contrast-enhanced ultrasound; hypoxia; oxygen delivery; radiosensitivity

Mesh:

Substances:

Year:  2019        PMID: 31124171      PMCID: PMC7064157          DOI: 10.1002/jum.15031

Source DB:  PubMed          Journal:  J Ultrasound Med        ISSN: 0278-4297            Impact factor:   2.153


  48 in total

Review 1.  Therapeutic use of ultrasound targeted microbubble destruction: a review of non-cardiac applications.

Authors:  R Bekeredjian; H A Katus; H F Kuecherer
Journal:  Ultraschall Med       Date:  2006-04       Impact factor: 6.548

Review 2.  Ultrasound microbubble contrast agents: fundamentals and application to gene and drug delivery.

Authors:  Katherine Ferrara; Rachel Pollard; Mark Borden
Journal:  Annu Rev Biomed Eng       Date:  2007       Impact factor: 9.590

3.  Acute and late morbidity in the treatment of advanced bladder carcinoma with accelerated radiotherapy, carbogen, and nicotinamide.

Authors:  Peter J Hoskin; Ana M Rojas; Heather Phillips; Michele I Saunders
Journal:  Cancer       Date:  2005-06-01       Impact factor: 6.860

4.  Drug Delivery from a Multi-faceted Ultrasound Contrast Agent: Influence of Shell Composition.

Authors:  Lauren J Jablonowski; Nutte T Teraphongphom; Margaret A Wheatley
Journal:  Mol Pharm       Date:  2017-08-25       Impact factor: 4.939

Review 5.  Principles and mechanisms of vessel normalization for cancer and other angiogenic diseases.

Authors:  Peter Carmeliet; Rakesh K Jain
Journal:  Nat Rev Drug Discov       Date:  2011-06       Impact factor: 84.694

Review 6.  Angiogenesis: how a tumor adapts to hypoxia.

Authors:  D E Richard; E Berra; J Pouysségur
Journal:  Biochem Biophys Res Commun       Date:  1999-12-29       Impact factor: 3.575

7.  Tumor hypoxia in cancer therapy.

Authors:  J Martin Brown
Journal:  Methods Enzymol       Date:  2007       Impact factor: 1.600

8.  Hypoxia and radiation therapy: past history, ongoing research, and future promise.

Authors:  Sara Rockwell; Iwona T Dobrucki; Eugene Y Kim; S Tucker Marrison; Van Thuc Vu
Journal:  Curr Mol Med       Date:  2009-05       Impact factor: 2.222

9.  Pharmacological modification of tumor blood flow: lack of correlation between alteration of mean arterial blood pressure and changes in tumor perfusion.

Authors:  H B Stone; A I Minchinton; M Lemmon; D Menke; J M Brown
Journal:  Int J Radiat Oncol Biol Phys       Date:  1992       Impact factor: 7.038

Review 10.  Role of angiogenesis in tumor growth and metastasis.

Authors:  Judah Folkman
Journal:  Semin Oncol       Date:  2002-12       Impact factor: 4.929

View more
  10 in total

Review 1.  Involvement of Ceramide Signalling in Radiation-Induced Tumour Vascular Effects and Vascular-Targeted Therapy.

Authors:  Deepa Sharma; Gregory J Czarnota
Journal:  Int J Mol Sci       Date:  2022-06-15       Impact factor: 6.208

2.  Development of a Dual Drug-Loaded, Surfactant-Stabilized Contrast Agent Containing Oxygen.

Authors:  Raj Patel; Quezia Lacerda; Brian E Oeffinger; John R Eisenbrey; Ankit K Rochani; Gagan Kaushal; Corinne E Wessner; Margaret A Wheatley
Journal:  Polymers (Basel)       Date:  2022-04-12       Impact factor: 4.967

Review 3.  Emerging Applications of Ultrasound-Contrast Agents in Radiation Therapy.

Authors:  Quezia Lacerda; Mohamed Tantawi; Dennis B Leeper; Margaret A Wheatley; John R Eisenbrey
Journal:  Ultrasound Med Biol       Date:  2021-02-27       Impact factor: 3.694

4.  A Robust Oxygen Microbubble Radiosensitizer for Iodine-125 Brachytherapy.

Authors:  Sheng Peng; Ruyuan Song; Qingguang Lin; Yanling Zhang; Yuanzhong Yang; Ma Luo; Zhihui Zhong; Xiaonan Xu; Ligong Lu; Shuhuai Yao; Fujun Zhang
Journal:  Adv Sci (Weinh)       Date:  2021-02-10       Impact factor: 16.806

5.  Metabolite profiling reveals a connection between aldehyde dehydrogenase 1A3 and GABA metabolism in breast cancer metastasis.

Authors:  Margaret L Dahn; Hayley R Walsh; Cheryl A Dean; Michael A Giacomantonio; Wasundara Fernando; J Patrick Murphy; Olivia L Walker; Marie-Claire D Wasson; Shashi Gujar; Devanand M Pinto; Paola Marcato
Journal:  Metabolomics       Date:  2022-01-06       Impact factor: 4.290

Review 6.  Making waves: how ultrasound-targeted drug delivery is changing pharmaceutical approaches.

Authors:  Lauren J Delaney; Selin Isguven; John R Eisenbrey; Noreen J Hickok; Flemming Forsberg
Journal:  Mater Adv       Date:  2022-02-23

Review 7.  Ultrasound and Nanomedicine for Cancer-Targeted Drug Delivery: Screening, Cellular Mechanisms and Therapeutic Opportunities.

Authors:  Chien-Hsiu Li; Yu-Chan Chang; Michael Hsiao; Ming-Hsien Chan
Journal:  Pharmaceutics       Date:  2022-06-16       Impact factor: 6.525

Review 8.  The promising shadow of microbubble over medical sciences: from fighting wide scope of prevalence disease to cancer eradication.

Authors:  Ali Jangjou; Amir Hossein Meisami; Kazem Jamali; Mohammad Hadi Niakan; Milad Abbasi; Mostafa Shafiee; Majid Salehi; Ahmad Hosseinzadeh; Ali Mohammad Amani; Ahmad Vaez
Journal:  J Biomed Sci       Date:  2021-06-21       Impact factor: 8.410

Review 9.  Breast cancer brain metastasis: insight into molecular mechanisms and therapeutic strategies.

Authors:  Yajie Wang; Fangzhou Ye; Yiran Liang; Qifeng Yang
Journal:  Br J Cancer       Date:  2021-07-05       Impact factor: 9.075

Review 10.  Preclinical Models of Brain Metastases in Breast Cancer.

Authors:  Natasha N Knier; Sierra Pellizzari; Jiangbing Zhou; Paula J Foster; Armen Parsyan
Journal:  Biomedicines       Date:  2022-03-13
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.